{
    "Trade/Device Name(s)": [
        "ID NOW Influenza A & B 2",
        "ID NOW Flu 2",
        "Alere i Flu 2",
        "Alere i Influenza A & B 2"
    ],
    "Submitter Information": "Abbott Diagnostics Scarborough, Inc.",
    "510(k) Number": "K232775",
    "Predicate Device Reference 510(k) Number(s)": [
        "K220801"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OCC",
        "OZE",
        "OOI"
    ],
    "Summary Letter Date": "September 8, 2023",
    "Summary Letter Received Date": "September 11, 2023",
    "Submission Date": "September 8, 2023",
    "Regulation Number(s)": [
        "21 CFR 866.3980",
        "21 CFR 862.2570"
    ],
    "Regulation Name(s)": [
        "Respiratory Viral Panel Multiplex Nucleic Acid Assay",
        "Instrumentation for Clinical Multiplex Test Systems"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A viral RNA",
        "Influenza B viral RNA"
    ],
    "Specimen Type(s)": [
        "Nasal swab",
        "Nasopharyngeal swab",
        "Nasal swab eluted in viral transport media",
        "Nasopharyngeal swab eluted in viral transport media"
    ],
    "Specimen Container(s)": [
        "Viral transport media"
    ],
    "Instrument(s)/Platform(s)": [
        "ID NOW Instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Isothermal nucleic acid amplification"
    ],
    "Methodologies": [
        "Molecular amplification",
        "Fluorescent molecular beacon detection",
        "Qualitative analysis"
    ],
    "Submission Type(s)": [
        "Assay",
        "Instrument",
        "Reagent",
        "Software",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for Abbott ID NOW Influenza A & B 2 rapid molecular assay using isothermal nucleic acid amplification on ID NOW Instrument",
    "Indications for Use Summary": "Aid in the differential diagnosis of influenza A and B viral infections in human patients with signs and symptoms of respiratory infection, using nasal or nasopharyngeal swabs tested directly or after elution in viral transport media.",
    "fda_folder": "Microbiology"
}